Oncology Nursing News Co-Editor in Chief Discusses Role of the Oncology Nurse in Leukemia Treatment
Between monitoring for medication adherence and ensuring that patients know when to call if their symptoms escalate, oncology nurses are a pivotal factor in decreasing mortality among patients with leukemia, says Stephanie Jackson, DNP, MSN, RN, AOCNS, BMTCN.
“It’s key assessment. It’s gathering the knowledge needed,” expressed Stephanie Jackson DNP, MSN, RN, AOCNS, BMTCN, Unit Director, Hematology/Stem Cell Transplantation, UCLA.
Jackson recently presented on leukemia essentials for the oncology nurse at the 5th Annual School of Nursing Oncology. In an interview with Oncology Nursing News®, Jackson, who is also co-edited in chief of Oncology Nursing News, provided a brief introduction to how nurses working in leukemia can help decrease morbidity and mortality among their patients.
She shared that “things are constantly changing in oncology, so as a nurse, especially an oncology nurses, it is our role to be competent, to have that knowledge, those skills, no matter what setting you’re in, and really know, what is the drug, when is it given, if there are oral therapies, are they taken with or without food, adherence to these drugs if they do miss a dose, and knowing those side effects…”
Oncology Nurses Provide Patients an Avenue to Supportive Care
November 12th 2019Palliative care is often associated with a patient entering end of life treatment and giving up on their treatment, but that isn't the reality of what id can do for patients. And oncology nurses can help guide patients to the right supportive care for them.
Hyman B. Muss Discusses the Importance of Nurses in Treating Pregnant Women With Breast Cancer
March 23rd 2016Hyman B. Muss, MD, professor of medicine at the University of North Carolina School of Medicine, discusses the vital roles that nurses play when it comes to treating pregnant women with breast cancer.
Kimberly J. Van Zee on Nomograms Helping in DCIS Treatment Decision-Making
March 18th 2016Kimberly J. Van Zee, MS, MD, FACS, attending surgeon at Memorial Sloan Kettering Cancer Center, discusses the institution's newly-developed nomogram that can help women make treatment decisions about ductal carcinoma in situ (DCIS).
